ETF Managers Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

ETF Managers Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$1.24M	Buy	+8,475	New	+$1.25M	0.04%	180
2022 Q4	–	Sell	-20,154	Closed	-$2.69M	–	611
2022 Q3	$2.69M	Sell	20,154 -58,812	-74%	-$8.94M	0.09%	135
2022 Q2	$12.3M	Sell	78,966 -52,601	-40%	-$8.1M	0.36%	66
2022 Q1	$20.7M	Sell	131,567 -83,960	-39%	-$12.2M	0.42%	62
2021 Q4	$27.6M	Sell	215,527 -33,749	-14%	-$4.44M	0.55%	67
2021 Q3	$32.8M	Sell	249,276 -11,448	-4%	-$1.73M	0.62%	61
2021 Q2	$46.7M	Buy	+260,724	New	+$45.2M	0.76%	47
2019 Q2	–	Sell	-947	Closed	-$135K	–	618
2019 Q1	$135K	Buy	947 +66	+7%	+$8.61K	0.01%	434
2018 Q4	$109K	Buy	881 +136	+18%	+$20.2K	0.01%	456
2018 Q3	$125K	Buy	+745	New	+$128K	﹤0.01%	364
2018 Q2	–	Sell	-483	Closed	-$71K	–	547
2018 Q1	$71K	Buy	483 +60	+14%	+$8.8K	﹤0.01%	435
2017 Q4	$58K	Buy	423 +60	+17%	+$8.32K	﹤0.01%	491
2017 Q3	$53K	Buy	363 +32	+10%	+$4.84K	﹤0.01%	376
2017 Q2	$51K	Buy	+331	New	+$50.6K	﹤0.01%	339
2016 Q1	$31K	Buy	+212	New	+$26.4K	0.02%	323

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

ETF Managers Group's JAZZ Position: Q1 2023 in Review

ETF Managers Group opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2023: 8,475 shares worth $1.24M. The stake represents 0.04% of the portfolio and ranks #180 among its holdings. This is a return to the name: ETF Managers Group previously reported a position in JAZZ as recently as Q3 2022.

ETF Managers Group first reported a position in JAZZ in Q1 2016 and has held it in 15 quarters since. The position peaked at $46.7M in Q2 2021. 471 funds tracked by Wall St. Rank hold JAZZ as of Q1 2023.

ETF Managers Group held 8,475 shares of Jazz Pharmaceuticals worth $1.24M as of Q1 2023.
Jazz Pharmaceuticals was a new ETF Managers Group position in Q1 2023.
Jazz Pharmaceuticals made up 0.04% of ETF Managers Group's portfolio in Q1 2023, its #180 holding.
ETF Managers Group first reported a position in Jazz Pharmaceuticals in Q1 2016 and has held it in 15 quarters since.
ETF Managers Group's Jazz Pharmaceuticals position peaked at $46.7M in Q2 2021.
471 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.